Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report

Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report

Abstract Background Pulmonary alveolar proteinosis (PAP) is characterized by the accumulation of surfactant proteins within the alveolar spaces. Autoimmune PAP (APAP) caused by elevated levels of GM-CSF autoantibodies (GM-Ab) is very rarely associated with systemic autoimmune disease. Here we report...

Full description

Bibliographic Details
Main Authors: S. Sato, K. Akasaka, H. Ohta, Y. Tsukahara, G. Kida, E. Tsumiyama, K. Kusano, T. Oba, T. Nishizawa, R. Kawabe, H. Yamakawa, M. Amano, H. Matsushima, T. Takada
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Pulmonary Medicine
Subjects:
Pulmonary alveolar proteinosis
Polymyositis
GM-CSF
Immunosuppressive treatment
Online Access:http://link.springer.com/article/10.1186/s12890-020-1110-5

Internet

http://link.springer.com/article/10.1186/s12890-020-1110-5

Similar Items